Patent Term Extension Application for ADZYNMA® (ADAMTS13, recombinant-krhn), Patent No. 7,517,522
🏛 Food and Drug Administration (FDA)FDA-2024-E-1284
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.